OBI — Ondine Biomedical Share News
0.000.00%
- £81.38m
- £75.95m
- CA$2.65m
Holding(s) in Company
RCS - Ondine Biomedical - Ondine and Mid Yorks Win National Award
RCS - Ondine Biomedical - Steriwave Up for 2025 “Product of the Year” Award
RCS - Ondine Biomedical - Expanding Steriwave Use Across Vancouver Island
RCS - Ondine Biomedical - Steriwave Expands into ENT Surgery in Spain
RCS - Ondine Biomedical - New Independent Study Supports Photodisinfection
RCS - Ondine Biomedical - Finalist for 2nd National Award for SSI reduction
RCS - Ondine Biomedical - Ondine shortlisted for HSJ Partnership Award
Brief: Ondine Biomedical Says Topline Results Significant In Steriwave ICU Study
Brief: Ondine Biomedical H1 Revenue USD 1.01 Million
Ondine Biomedical - Ondine Biomedical Continues Growth in H1 2025
RCS - Ondine Biomedical - Steriwave Now Protecting Patients with Cancer
Ondine Biomedical - Notice of Interim Results & Investor Presentation
RCS - Ondine Biomedical - Ondine Presents Major Economic Benefits at ICPIC
RCS - Ondine Biomedical - Steriwave proven to be effective against C Auris
Ondine Biomedical - Grant of Options
RCS - Ondine Biomedical - Steriwave Featured on CNBC’s Worldwide Exchange
Ondine Biomedical - Notification of major holdings - hInsight
Ondine Biomedical - Notification of major holdings - Pentwater